Glück Conviction Score™ ⓘ
NTLA
Intellia Therapeutics, Inc.
Effektiv: Risiko-Ausstieg
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
77,4
56 neu, 132 erhöht, 407,1M $ netto
Aktivist
26,8
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 13.63 | -11.1 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 13.39 | -9.6 % vs SMA200 | |
| SMA-Cross | Bullisch | 10 % | GOLDEN | vor 66 Tagen @ 13.47 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 13.10 | EMA50: 13.30 | |
| MACD-Histogramm | Bärisch | 10 % | -0.121 | Bearisch | |
| RSI(14) | Neutral | 10 % | 41.9 | Neutral (30–70) | |
| Stoch %K(14) | Bullisch | 5 % | 8.2 | Überverkauft | |
| ADX(14)+DI | Neutral | 10 % | 12.6 | +DI: 24.5 / −DI: 20.8 | |
| Z-Score(60) | Neutral | 5 % | -1.46 | In Range | |
| 52W-Position | Neutral | 5 % | 20.4 % | Hoch 27.98 / Tief 8.04 | |
| Bollinger(20,2σ) | Bullisch | 5 % | 18.7 % | Upper 14.49 / Mid 13.03 / Lower 11.56 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0073 | R²=0.02 / annualisiert -13.6 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | Clark Eliana | Officer, EVP, Chief Technical Officer | Open Market Sale | -607 | 13,78 | -8.364,46 | -4,1% | |
| 2026-03-02 | BASTA JAMES | Officer, EVP, General Counsel | Open Market Sale | -1.211 | 13,78 | -16.687,58 | -8,3% | |
| 2026-01-05 | LEONARD JOHN M | Director, Officer, President and CEO | Open Market Sale | -34.146 | 9,21 | -314.484,66 | -155,7% | |
| 2026-01-05 | Dube Michael P | Officer, VP, Chief Accounting Officer | Open Market Sale | -2.989 | 9,21 | -27.528,69 | -13,6% | |
| 2026-01-05 | Lebwohl David | Officer, EVP, Chief Medical Officer | Open Market Sale | -11.903 | 9,21 | -109.626,63 | -54,3% | |
| 2026-01-05 | Dulac Edward J III | Officer, EVP, Chief Financial Officer | Open Market Sale | -6.379 | 9,21 | -58.750,59 | -29,1% | |
| 2026-01-05 | Schultes Birgit C | Officer, EVP, Chief Scientific Officer | Open Market Sale | -8.508 | 9,21 | -78.358,68 | -38,8% | |
| 2026-01-05 | Clark Eliana | Officer, EVP, Chief Technical Officer | Open Market Sale | -9.515 | 9,21 | -87.633,15 | -43,4% | |
| 2026-01-05 | BASTA JAMES | Officer, EVP, General Counsel | Open Market Sale | -10.397 | 9,21 | -95.756,37 | -47,4% | |
| 2026-01-05 | Cohen Fred E | Director | Open Market Purchase | 150.000 | 9,35 | 1.402.500,00 | +694,5% | |
| 2025-12-11 | LEONARD JOHN M | Director, Officer, President and CEO | Open Market Sale | -49.959 | 9,49 | -474.110,91 | -234,8% | |
| 2025-12-11 | LEONARD JOHN M | Director, Officer, President and CEO | Open Market Sale | -5.355 | 9,59 | -51.354,45 | -25,4% | |
| 2025-12-11 | LEONARD JOHN M | Director, Officer, President and CEO | Open Market Sale | -32.832 | 9,47 | -310.919,04 | -154,0% | |
| 2025-10-01 | Schultes Birgit C | Officer, EVP, Chief Scientific Officer | Open Market Sale | -31 | 17,38 | -538,78 | -0,3% | |
| 2025-10-01 | Dube Michael P | Officer, VP, Chief Accounting Officer | Open Market Sale | -1.871 | 17,38 | -32.517,98 | -16,1% | |
| 2025-08-20 | CHASE WILLIAM J | Director | Open Market Purchase | 100.000 | 10,03 | 1.003.000,00 | +496,7% | |
| 2025-07-23 | Dulac Edward J III | Officer, EVP, Chief Financial Officer | Open Market Sale | -7.462 | 14,02 | -104.617,24 | -51,8% | |
| 2025-07-02 | Dube Michael P | Officer, VP, Chief Accounting Officer | Open Market Sale | -2.503 | 9,95 | -24.904,85 | -12,3% | |
| 2025-07-01 | GOODMAN JESSE | Director | Open Market Sale | -1.547 | 9,23 | -14.278,81 | -7,1% | |
| 2025-07-01 | Clark Eliana | Officer, EVP, Chief Technical Officer | Open Market Sale | -1.022 | 9,82 | -10.036,04 | -5,0% | |
| 2025-06-30 | GOODMAN JESSE | Director | Open Market Sale | -1.547 | 9,56 | -14.789,32 | -7,3% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 14.509.247 | 14.207.324 | 301.923 | 186.008.545 | Aufgestockt | +2,1% | |
| BlackRock, Inc. | 12.155.806 | 10.276.849 | 1.878.957 | 155.837.437 | Aufgestockt | +18,3% | |
| VANGUARD GROUP INC | 13.010.001 | 0 | 13.010.001 | 116.959.909 | Neu | +100,0% | |
| STATE STREET CORP | 6.922.676 | 6.418.836 | 503.840 | 88.748.706 | Aufgestockt | +7,8% | |
| D. E. Shaw & Co., Inc. | 5.728.177 | 5.414.164 | 314.013 | 73.435.230 | Aufgestockt | +5,8% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.084.105 | 0 | 5.084.105 | 65.178.226 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 4.705.901 | 2.698.738 | 2.007.163 | 60.329.651 | Aufgestockt | +74,4% | |
| REGENERON PHARMACEUTICALS, INC. | 3.702.995 | 3.702.995 | 0 | 47.472.396 | Unverändert | 0,0% | |
| UBS Group AG | 3.258.258 | 1.237.736 | 2.020.522 | 41.770.866 | Aufgestockt | +163,2% | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.851.472 | 2.696.187 | 155.285 | 36.563.024 | Aufgestockt | +5,8% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.702.665 | 1.888.365 | 814.300 | 34.648.165 | Aufgestockt | +43,1% | |
| DIMENSIONAL FUND ADVISORS LP | 2.318.110 | 1.931.849 | 386.261 | 29.708.722 | Aufgestockt | +20,0% | |
| MORGAN STANLEY | 2.081.397 | 2.327.852 | -246.455 | 26.683.520 | Reduziert | -10,6% | |
| FMR LLC | 2.067.222 | 1.759.898 | 307.324 | 26.501.787 | Aufgestockt | +17,5% | |
| Sumitomo Mitsui Trust Group, Inc. | 1.973.061 | 2.192.461 | -219.400 | 25.294.642 | Reduziert | -10,0% | |
| Amova Asset Management Americas, Inc. | 1.973.061 | 2.192.461 | -219.400 | 25.274.911 | Reduziert | -10,0% | |
| Contrarius Group Holdings Ltd | 1.911.839 | 714.480 | 1.197.359 | 24.509.776 | Aufgestockt | +167,6% | |
| JUPITER ASSET MANAGEMENT LTD | 1.781.063 | 1.037.918 | 743.145 | 22.833.228 | Aufgestockt | +71,6% | |
| TWO SIGMA ADVISERS, LP | 2.346.317 | 0 | 2.346.317 | 21.093.390 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1.628.241 | 1.455.619 | 172.622 | 20.874.050 | Aufgestockt | +11,9% | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.611.534 | 1.737.450 | -125.916 | 20.659.866 | Reduziert | -7,2% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.397.243 | 0 | 1.397.243 | 17.912.655 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 1.381.703 | 1.242.378 | 139.325 | 17.713.432 | Aufgestockt | +11,2% | |
| JANE STREET GROUP, LLC | 1.351.057 | 901.771 | 449.286 | 17.320.550 | Aufgestockt | +49,8% | |
| RENAISSANCE TECHNOLOGIES LLC | 1.672.700 | 0 | 1.672.700 | 15.037.573 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 1.117.641 | 2.137.950 | -1.020.309 | 14.328.158 | Reduziert | -47,7% | |
| STIFEL FINANCIAL CORP | 1.012.706 | 931.391 | 81.315 | 12.982.921 | Aufgestockt | +8,7% | |
| NORTHERN TRUST CORP | 966.293 | 872.579 | 93.714 | 12.387.876 | Aufgestockt | +10,7% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 941.285 | 945.756 | -4.471 | 12.067.274 | Reduziert | -0,5% | |
| CAPITAL FUND MANAGEMENT S.A. | 796.622 | 395.026 | 401.596 | 10.212.694 | Aufgestockt | +101,7% | |
| Connor, Clark & Lunn Investment Management Ltd. | 748.636 | 259.709 | 488.927 | 9.597.514 | Aufgestockt | +188,3% | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 724.286 | 731.421 | -7.135 | 9.285.347 | Reduziert | -1,0% | |
| AQR CAPITAL MANAGEMENT LLC | 630.529 | 313.695 | 316.834 | 8.083.382 | Aufgestockt | +101,0% | |
| Marex Group plc | 623.600 | 623.601 | -1 | 7.994.552 | Reduziert | 0,0% | |
| Caption Management, LLC | 584.900 | 110.000 | 474.900 | 7.498.418 | Aufgestockt | +431,7% | |
| BNP PARIBAS FINANCIAL MARKETS | 579.430 | 591.277 | -11.847 | 7.428.293 | Reduziert | -2,0% | |
| RAYMOND JAMES FINANCIAL INC | 576.930 | 401.661 | 175.269 | 7.396.243 | Aufgestockt | +43,6% | |
| Vestmark Advisory Solutions, Inc. | 550.144 | 443.927 | 106.217 | 7.052.846 | Aufgestockt | +23,9% | |
| SIMPLEX TRADING, LLC | 535.000 | 841.800 | -306.800 | 6.858.700 | Reduziert | -36,4% | |
| JPMORGAN CHASE & CO | 743.698 | 0 | 743.698 | 6.685.845 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 474.549 | 464.185 | 10.364 | 6.083.718 | Aufgestockt | +2,2% | |
| ROYAL BANK OF CANADA | 465.499 | 39.378 | 426.121 | 5.968.000 | Aufgestockt | +1082,1% | |
| Birchview Capital, LP | 445.400 | 315.400 | 130.000 | 5.710.028 | Aufgestockt | +41,2% | |
| Invesco Ltd. | 434.753 | 433.290 | 1.463 | 5.573.533 | Aufgestockt | +0,3% | |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 429.540 | 578.562 | -149.022 | 5.506.703 | Reduziert | -25,8% | |
| FEDERATED HERMES, INC. | 368.617 | 354.947 | 13.670 | 4.725.670 | Aufgestockt | +3,9% | |
| Casdin Capital, LLC | 355.000 | 0 | 355.000 | 4.551.100 | Neu | +100,0% | |
| ARMISTICE CAPITAL, LLC | 336.000 | 1.156.000 | -820.000 | 4.307.520 | Reduziert | -70,9% | |
| WELLS FARGO & COMPANY/MN | 333.897 | 433.742 | -99.845 | 4.280.563 | Reduziert | -23,0% | |
| Point72 Asset Management, L.P. | 297.011 | 24.100 | 272.911 | 3.807.681 | Aufgestockt | +1132,4% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 14.509.247 | 14.207.324 | +2,1% | 186.008.545 | 13,44 |
| BlackRock, Inc. | 12.155.806 | 10.276.849 | +18,3% | 155.837.437 | 11,26 |
| STATE STREET CORP | 6.922.676 | 6.418.836 | +7,8% | 88.748.706 | 6,41 |
| D. E. Shaw & Co., Inc. | 5.728.177 | 5.414.164 | +5,8% | 73.435.230 | 5,31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.084.105 | 0 | +100,0% | 65.178.226 | 4,71 |
| TWO SIGMA INVESTMENTS, LP | 4.705.901 | 2.698.738 | +74,4% | 60.329.651 | 4,36 |
| REGENERON PHARMACEUTICALS, INC. | 3.702.995 | 3.702.995 | 0,0% | 47.472.396 | 3,43 |
| UBS Group AG | 3.258.258 | 1.237.736 | +163,2% | 41.770.866 | 3,02 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.851.472 | 2.696.187 | +5,8% | 36.563.024 | 2,64 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.702.665 | 1.888.365 | +43,1% | 34.648.165 | 2,50 |
| DIMENSIONAL FUND ADVISORS LP | 2.318.110 | 1.931.849 | +20,0% | 29.708.722 | 2,15 |
| MORGAN STANLEY | 2.081.397 | 2.327.852 | -10,6% | 26.683.520 | 1,93 |
| FMR LLC | 2.067.222 | 1.759.898 | +17,5% | 26.501.787 | 1,92 |
| Sumitomo Mitsui Trust Group, Inc. | 1.973.061 | 2.192.461 | -10,0% | 25.294.642 | 1,83 |
| Amova Asset Management Americas, Inc. | 1.973.061 | 2.192.461 | -10,0% | 25.274.911 | 1,83 |
| Contrarius Group Holdings Ltd | 1.911.839 | 714.480 | +167,6% | 24.509.776 | 1,77 |
| JUPITER ASSET MANAGEMENT LTD | 1.781.063 | 1.037.918 | +71,6% | 22.833.228 | 1,65 |
| GOLDMAN SACHS GROUP INC | 1.628.241 | 1.455.619 | +11,9% | 20.874.050 | 1,51 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.611.534 | 1.737.450 | -7,2% | 20.659.866 | 1,49 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.397.243 | 0 | +100,0% | 17.912.655 | 1,29 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 301 | 122,0 | 1.546 |
| 31.12.2025 | ✓ | 292 | 114,6 | 1.018 |
| 30.09.2025 | ✓ | 288 | 118,5 | 2.025 |
| 30.06.2025 | ✓ | 276 | 104,7 | 959 |
| 31.03.2025 | ✓ | 292 | 109,6 | 767 |
| 31.12.2024 | ✓ | 287 | 107,3 | 1.243 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| WASATCH ADVISORS LP | 313.685 | 2.820.028 |
| Connor, Clark & Lunn Investment Management Ltd. | 259.709 | 2.334.784 |
| Bridgewater Associates, LP | 223.166 | 2.006.262 |
| Quadrature Capital Ltd | 216.041 | 1.942.209 |
| TUDOR INVESTMENT CORP ET AL | 204.076 | 1.834.643 |
| Qube Research & Technologies Ltd | 158.235 | 1.422.533 |
| IMC-Chicago, LLC | 126.903 | 1.140.858 |
| Edgestream Partners, L.P. | 111.159 | 999.319 |
| Atom Investors LP | 92.540 | 831.935 |
| Freestone Grove Partners LP | 88.406 | 794.770 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 5.414.164 | 3.185.764 | +143.0 % | 48.673.335 |
| ARK Investment Management LLC | 14.207.324 | 2.288.146 | +19.2 % | 127.723.840 |
| VANGUARD GROUP INC | 13.010.001 | 1.965.181 | +17.8 % | 116.959.909 |
| CITADEL ADVISORS LLC | 2.137.950 | 1.568.995 | +275.8 % | 19.220.171 |
| STATE STREET CORP | 6.418.836 | 1.447.967 | +29.1 % | 57.705.336 |
| RENAISSANCE TECHNOLOGIES LLC | 1.672.700 | 1.021.700 | +156.9 % | 15.037.573 |
| BlackRock, Inc. | 10.276.849 | 1.001.032 | +10.8 % | 92.388.870 |
| BANK OF AMERICA CORP /DE/ | 1.242.378 | 636.852 | +105.2 % | 11.168.977 |
| JANE STREET GROUP, LLC | 901.771 | 578.672 | +179.1 % | 8.106.921 |
| BNP PARIBAS FINANCIAL MARKETS | 591.277 | 541.026 | +1076.6 % | 5.315.580 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Contrarius Group Holdings Ltd | 714.480 | -5.175.456 | -87.9 % | 6.423.175 |
| MORGAN STANLEY | 2.327.852 | -3.694.724 | -61.3 % | 20.927.396 |
| GOLDMAN SACHS GROUP INC | 1.455.619 | -2.823.058 | -66.0 % | 13.086.015 |
| MILLENNIUM MANAGEMENT LLC | 126.426 | -481.137 | -79.2 % | 1.136.570 |
| ROYAL BANK OF CANADA | 39.378 | -425.149 | -91.5 % | 355.000 |
| Walleye Capital LLC | 27.580 | -374.320 | -93.1 % | 247.944 |
| UBS Group AG | 1.237.736 | -366.326 | -22.8 % | 11.127.247 |
| JUPITER ASSET MANAGEMENT LTD | 1.037.918 | -323.931 | -23.8 % | 9.330.883 |
| Caption Management, LLC | 110.000 | -209.928 | -65.6 % | 988.900 |
| Walleye Trading LLC | 44.163 | -182.537 | -80.5 % | 397.025 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,03 % | 5.945.571 | Neu | |
| 29.04.2026 | Vanguard Portfolio Management | Passiv (13G) | 5,30 % | 6.266.007 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -11,23 pp | |
| 12.02.2026 | GOLDMAN SACHS & CO. LLC | Passiv (13G/A) | 2,70 % | 3.157.178 | -2,40 pp | |
| 12.02.2026 | THE GOLDMAN SACHS GROUP, INC. | Passiv (13G/A) | 2,70 % | 3.157.178 | -2,40 pp | |
| 11.02.2026 | Contrarius Investment Management (Bermuda) Ltd | Passiv (13G/A) | 0,60 % | 714.480 | -4,90 pp | |
| 11.02.2026 | Contrarius Investment Management Ltd | Passiv (13G/A) | 0,60 % | 714.480 | -4,90 pp | |
| 09.02.2026 | STATE STREET CORPORATION | Passiv (13G) | 5,50 % | 6.418.836 | +1,10 pp | |
| 03.02.2026 | ARK Investment Management LLC | Passiv (13G/A) | 12,27 % | 14.207.324 | +1,17 pp | |
| 03.02.2026 | Catherine D. Wood | Passiv (13G/A) | 12,27 % | 14.207.324 | +1,17 pp | |
| 30.01.2026 | The Vanguard Group | Passiv (13G/A) | 11,23 % | 13.010.001 | +1,23 pp | |
| 12.11.2025 | Contrarius Investment Management Ltd | Passiv (13G) | 5,50 % | 5.889.936 | Neu | |
| 12.11.2025 | Contrarius Investment Management (Bermuda) Ltd | Passiv (13G) | 5,50 % | 5.889.936 | Neu | |
| 12.11.2025 | GOLDMAN SACHS & CO. LLC | Passiv (13G) | 5,10 % | 5.498.262 | Neu | |
| 12.11.2025 | THE GOLDMAN SACHS GROUP, INC. | Passiv (13G) | 5,10 % | 5.498.262 | Neu | |
| 04.11.2025 | ARK Investment Management LLC | Passiv (13G/A) | 11,10 % | 11.919.178 | -0,10 pp | |
| 04.11.2025 | Catherine D. Wood | Passiv (13G/A) | 11,10 % | 11.919.178 | Neu | |
| 13.05.2025 | STATE STREET CORPORATION | Passiv (13G) | 4,40 % | 4.510.261 | Neu | |
| 17.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 8,20 % | 8.453.014 | Neu | |
| 08.01.2025 | The Vanguard Group | Passiv (13G/A) | 10,00 % | 10.189.953 | +0,68 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 9,32 % | 8.347.449 | +0,04 pp | |
| 29.01.2024 | ARK | Passiv (13G/A) | 12,74 % | 11.412.449 | +2,34 pp | |
| 24.01.2024 | : STATE STREET CORPORATION | Passiv (13G/A) | 5,29 % | 0 | +1,83 pp | |
| 08.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 10,10 % | 9.010.695 | +1,40 pp | |
| 10.02.2023 | ARK Investment Management LLC | Passiv (13G/A) | 11,20 % | 9.420.782 | +0,56 pp | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 9,28 % | 7.810.226 | +0,62 pp | |
| 25.01.2023 | . BlackRock, Inc. | Passiv (13G) | 8,70 % | 7.254.921 | +1,10 pp | |
| 14.02.2022 | Nikko Asset Management Americas, Inc. | Passiv (13G/A) | 3,70 % | 2.753.903 | -4,24 pp | |
| 11.02.2022 | REGENERON PHARMACEUTICALS, INC. | Passiv (13G/A) | 4,98 % | 3.702.995 | Neu | |
| 10.02.2022 | The Vanguard Group | Passiv (13G/A) | 8,66 % | 6.442.355 | +0,68 pp | |
| 09.02.2022 | ARK Investment Management LLC | Passiv (13G/A) | 10,64 % | 7.916.882 | -6,76 pp | |
| 04.02.2022 | Nikko Asset Management Co., Ltd. (“NAM”) | Passiv (13G/A) | 3,70 % | 2.753.903 | -4,24 pp | |
| 04.02.2022 | Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”) | Passiv (13G/A) | 3,70 % | 2.753.903 | -4,24 pp | |
| 03.02.2022 | . BlackRock, Inc. | Passiv (13G/A) | 7,60 % | 5.620.376 | -1,00 pp | |
| 26.11.2021 | ARK | Passiv (13G/A) | 10,40 % | 7.642.452 | -7,48 pp |
Stammdaten
Intellia Therapeutics, Inc., ein Genombearbeitungsunternehmen, konzentriert sich auf die Entwicklung von Therapeutika. Die In-vivo-Programme des Unternehmens umfassen NTLA-2001, das sich in Phase-1-Klinikstudien zur Behandlung der Transthyretin-Amyloidose befindet; und NTLA-2002 zur Behandlung von hereditärem Angioödem sowie weitere leberfokussierte Programme, die Hämophilie A und Hämophilie B, Hyperoxalurie Typ 1 und Alpha-1-Antitrypsin-Mangel umfassen. Die Ex-vivo-Pipeline umfasst NTLA-5001 zur Behandlung akuter myeloischer Leukämie und Eigenentwicklungsprogramme zur Entwicklung manipulierter Zelltherapien zur Behandlung verschiedener onkologischer und Autoimmunerkrankungen. Darüber hinaus bietet das Unternehmen Tools an, die das Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9)-System umfassen. Intellia Therapeutics, Inc. hat Lizenz- und Kooperationsvereinbarungen mit Novartis Institutes for BioMedical Research, Inc. zur Manipulation hämatopoetischer Stammzellen zur Behandlung der Sichelzellenkrankheit; Regeneron Pharmaceuticals, Inc. zur Co-Entwicklung potenzieller Produkte zur Behandlung von Hämophilie A und Hämophilie B; Ospedale San Raffaele; und eine strategische Kooperation mit SparingVision SAS zur Entwicklung neuartiger genomischer Medikamente unter Verwendung der CRISPR/Cas9-Technologie zur Behandlung okularer Erkrankungen. Das Unternehmen war früher unter dem Namen AZRN, Inc. bekannt. Intellia Therapeutics, Inc. wurde 2014 gegründet und hat seinen Hauptsitz in Cambridge, Massachusetts.
Unternehmen & Branche
| Name | Intellia Therapeutics, Inc. |
|---|---|
| Ticker | NTLA |
| CIK | 0001652130 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2835 · In Vitro & In Vivo Diagnostic Substances |
Wertpapier & Kennzahlen
| CUSIP | 45826J105 |
|---|---|
| ISIN | US45826J1051 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,44 Mrd. USD |
| Beta | 1,87 |
Bewertung
| KBV (P/B) | 2,14 vs. 8,47 (2021) ▼ |
|---|---|
| KUV (P/S) | 21,23 vs. 266,46 (2021) ▼ |
| FCF-Rendite | -27,6 % vs. -2,7 % (2021) ▼ |
Qualität & Bilanz
| Operative Marge | -651,7 % vs. -810,4 % (2021) ▲ |
|---|---|
| Nettomarge | -609,9 % vs. -810,5 % (2021) ▲ |
| ROIC | -54,0 % vs. -24,0 % (2021) ▼ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 8,47 | 2,46 | 2,70 | 1,36 | 1,56 | |
| KUV (P/S) | 266,46 | 58,31 | 78,17 | 20,56 | 15,45 | |
| FCF-Rendite | -2,7 % | -11,4 % | -14,4 % | -29,8 % | -37,9 % | |
| Qualität & Bilanz | ||||||
| Operative Marge | -810,4 % | -879,0 % | -1.420,5 % | -923,1 % | -651,7 % | |
| Nettomarge | -810,5 % | -909,8 % | -1.326,5 % | -896,8 % | -609,9 % | |
| ROIC | -24,0 % | -34,7 % | -41,3 % | -48,0 % | -54,0 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 15.048.000 | -96.231.000 | -0,81 | 758.779.000 | 620.939.000 |
| 2025-12-31 | 10-K | 67.671.000 | -412.694.000 | -3,81 | 842.127.000 | 671.394.000 |
| 2025-09-30 | 10-Q | 13.782.000 | -101.324.000 | -0,92 | 925.275.000 | 748.422.000 |
| 2025-06-30 | 10-Q | 14.245.000 | -101.255.000 | -0,98 | 898.894.000 | 715.255.000 |
| 2025-03-31 | 10-Q | 16.627.000 | -114.329.000 | -1,10 | 986.163.000 | 779.919.000 |
| 2024-12-31 | 10-K | 57.877.000 | -519.021.000 | -5,25 | 1.191.015.000 | 871.956.000 |
| 2024-09-30 | 10-Q | 9.111.000 | -135.712.000 | -1,34 | 1.173.351.000 | 962.615.000 |
| 2024-06-30 | 10-Q | 6.957.000 | -146.975.000 | -1,52 | 1.191.536.000 | 971.062.000 |
| 2024-03-31 | 10-Q | 28.935.000 | -107.436.000 | -1,12 | 1.259.589.000 | 1.036.137.000 |
| 2023-12-31 | 10-K | 36.275.000 | -481.192.000 | -5,42 | 1.300.977.000 | 1.050.169.000 |
| 2023-09-30 | 10-Q | 11.992.000 | -122.224.000 | -1,38 | 1.243.349.000 | 1.037.414.000 |
| 2023-06-30 | 10-Q | 13.594.000 | -123.681.000 | -1,40 | 1.323.240.000 | 1.104.888.000 |
| 2023-03-31 | 10-Q | 12.606.000 | -103.126.000 | -1,17 | 1.417.889.000 | 1.190.843.000 |
| 2022-12-31 | 10-K | 52.121.000 | -474.186.000 | -6,16 | 1.520.114.000 | 1.235.584.000 |
| 2022-09-30 | 10-Q | 13.266.000 | -113.229.000 | -1,49 | 1.084.458.000 | 824.951.000 |
| 2022-06-30 | 10-Q | 14.030.000 | -100.678.000 | -1,33 | 1.110.424.000 | 880.547.000 |
| 2022-03-31 | 10-Q | 11.252.000 | -146.872.000 | -1,96 | 1.202.788.000 | 953.754.000 |
| 2021-12-31 | 10-K | 33.053.000 | -267.892.000 | -3,78 | 1.294.464.000 | 1.040.244.000 |
| 2021-09-30 | 10-Q | 7.204.000 | -71.644.000 | -0,97 | 1.334.961.000 | 1.107.098.000 |
| 2021-06-30 | 10-Q | 6.550.000 | -68.806.000 | -1,01 | 672.243.000 | 494.813.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 11.05.2026 | 15,0 Mio. USD | -0,81 |
| Q3 2025 | 30.09.2025 | 06.11.2025 | 13,8 Mio. USD | -0,92 |
| Q2 2025 | 30.06.2025 | 06.11.2025 | 14,2 Mio. USD | -0,98 |
| Q1 2025 | 31.03.2025 | 11.05.2026 | 16,6 Mio. USD | -1,10 |
| Q3 2024 | 30.09.2024 | 06.11.2025 | 9,1 Mio. USD | -1,34 |
| Q2 2024 | 30.06.2024 | 06.11.2025 | 7,0 Mio. USD | -1,52 |
| Q1 2024 | 31.03.2024 | 06.11.2025 | 28,9 Mio. USD | -1,12 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | 12,0 Mio. USD | -1,38 |
| Q2 2023 | 30.06.2023 | 07.11.2024 | 13,6 Mio. USD | -1,40 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 11.05.2026 | 10-Q | – | – | SEC » |
| 26.02.2026 | 10-K | 31.12.2025 | 57 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 27.02.2025 | 10-K | 31.12.2024 | 58 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 22.02.2024 | 10-K | 31.12.2023 | 53 Tage | SEC » |
| 09.11.2023 | 10-Q | 30.09.2023 | 40 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 04.05.2023 | 10-Q | 31.03.2023 | 34 Tage | SEC » |
| 23.02.2023 | 10-K | 31.12.2022 | 54 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 05.05.2022 | 10-Q | 31.03.2022 | 35 Tage | SEC » |
| 24.02.2022 | 10-K | 31.12.2021 | 55 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 26.02.2021 | 10-K | 31.12.2020 | 57 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
| 06.08.2020 | 10-Q | 30.06.2020 | 37 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 07.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 12.06.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 26.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 of this current report on Form 8-K. The full text of this press release is attached hereto as Exhibit 99.1… |
| 14.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 15.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 22.06.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 12.04.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 18.575 | 14,28 | 265.251 |
| 2026-05-12 | 184 | 14,42 | 2.653 |
| 2026-05-06 | 1.208 | 13,31 | 16.078 |
| 2026-05-05 | 58.300 | 13,87 | 808.621 |
| 2026-05-04 | 1.247 | 13,26 | 16.535 |
| 2026-05-01 | 1.246 | 13,48 | 16.796 |
| 2026-04-30 | 190.818 | 12,45 | 2.375.684 |
| 2026-04-28 | 602.801 | 13,04 | 7.860.525 |
| 2026-04-24 | 27.013 | 15,87 | 428.696 |
| 2026-04-22 | 60.755 | 15,31 | 930.159 |
| 2026-04-21 | 531 | 15,21 | 8.077 |
| 2026-04-20 | 2.900 | 14,95 | 43.355 |
| 2026-04-17 | 20.212 | 14,16 | 286.202 |
| 2026-04-16 | 5.259 | 14,94 | 78.569 |
| 2026-04-15 | 6.995 | 14,78 | 103.386 |
| 2026-04-14 | 12.468 | 14,26 | 177.794 |
| 2026-04-13 | 8.037 | 13,49 | 108.419 |
| 2026-04-10 | 6.651 | 13,83 | 91.983 |
| 2026-04-07 | 1.388 | 13,30 | 18.460 |
| 2026-04-06 | 229 | 13,13 | 3.007 |
| 2026-04-01 | 1.186 | 12,82 | 15.205 |
| 2026-03-27 | 599 | 13,24 | 7.931 |
| 2026-03-24 | 2.475 | 13,11 | 32.447 |
| 2026-03-10 | 277.080 | 13,89 | 3.848.641 |
| 2026-03-05 | 15.086 | 13,82 | 208.489 |
| 2026-03-03 | 1.489.328 | 15,44 | 22.995.224 |
| 2026-02-27 | 63.721 | 14,28 | 909.936 |
| 2026-02-26 | 14.110 | 13,42 | 189.356 |
| 2026-02-25 | 19.608 | 13,58 | 266.277 |
| 2026-02-24 | 12.586 | 13,16 | 165.632 |
| 2026-02-23 | 72.179 | 12,64 | 912.343 |
| 2026-02-10 | 87 | 12,49 | 1.087 |
| 2026-02-09 | 6.706 | 12,28 | 82.350 |
| 2026-02-06 | 150.693 | 11,09 | 1.671.185 |
| 2026-02-03 | 433 | 13,06 | 5.655 |
| 2026-02-02 | 35 | 13,15 | 460 |
| 2026-01-30 | 3.143 | 13,90 | 43.688 |
| 2026-01-28 | 34.001 | 14,83 | 504.235 |
| 2026-01-27 | 15.223 | 13,95 | 212.361 |
| 2026-01-26 | 13.500 | 14,63 | 197.505 |
| 2026-01-23 | 46.980 | 15,90 | 746.982 |
| 2026-01-22 | 129.868 | 14,03 | 1.822.048 |
| 2026-01-20 | 101.383 | 12,50 | 1.267.288 |
| 2026-01-16 | 23.449 | 11,87 | 278.340 |
| 2026-01-13 | 4.294 | 11,43 | 49.080 |
| 2026-01-09 | 6.783 | 10,52 | 71.357 |
| 2026-01-08 | 7.450 | 10,13 | 75.469 |
| 2026-01-06 | 3.267 | 9,37 | 30.612 |
| 2025-12-30 | 9 | 9,14 | 82 |
| 2025-12-22 | 11.773 | 9,23 | 108.665 |
| 2025-12-18 | 8.279 | 8,79 | 72.772 |
| 2025-12-16 | 790 | 9,14 | 7.221 |